RankingsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from operations

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】

Market cap
¥573.5B
P/E ratio
16.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 202560,928-16.13%
Mar 31, 202472,649+95.57%
Mar 31, 202337,147-19.32%
Mar 31, 202246,043+18.64%
Mar 31, 202138,808-2.85%
Mar 31, 202039,947+21.44%
Mar 31, 201932,894-23.22%
Mar 31, 201842,843+295.12%
Mar 31, 201710,843-51.86%
Mar 31, 201622,525-11.27%
Mar 31, 201525,386-4.87%
Mar 31, 201426,686

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)